Vivos Therapeutics, Inc.

NasdaqCM VVOS

Vivos Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD -12.50 M

Vivos Therapeutics, Inc. Operating Cash Flow is USD -12.50 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -2.47% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Vivos Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -12.20 M, a 41.10% change year over year.
Vivos Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -20.71 M, a -35.96% change year over year.
Vivos Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -15.23 M, a -318.95% change year over year.
Vivos Therapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -3.64 M.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

NasdaqCM: VVOS

Vivos Therapeutics, Inc.

CEO	Mr. R. Kirk Huntsman
IPO Date	Dec. 11, 2020
Location	United States
Headquarters	9137 Ridgeline Boulevard
Employees	114
Sector	Healthcare
Industries Dental Care 3D Printing Biotechnology Clinical Trials Medical Instruments Telehealth

Description

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Key trends

Past 5 years